tiprankstipranks
Health and Happiness (H&H) International Holdings Limited (HK:1112)
:1112
Want to see HK:1112 full AI Analyst Report?

Health and Happiness (H&H) International Holdings (1112) AI Stock Analysis

2 Followers

Top Page

HK:1112

Health and Happiness (H&H) International Holdings

(1112)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
HK$13.50
▼(-4.86% Downside)
Action:Reiterated
Date:03/26/26
The score is held back primarily by volatile profitability alongside elevated leverage, which increases risk despite solid gross margins and positive free cash flow. Technicals further weigh on the score as the stock trades below major moving averages with bearish momentum. Valuation is also a headwind given the high P/E and only modest dividend yield.
Positive Factors
Gross Margin Strength
Sustained gross margins near 60–64% provide durable unit economics for H&H, enabling the company to absorb channel discounts, promotions and some input-cost pressure while still funding marketing and innovation. This margin buffer supports stable gross profit and long-term reinvestment capacity.
Negative Factors
Elevated Leverage
A debt-to-equity ratio around 1.5–1.6 limits financial flexibility and increases sensitivity to profit fluctuations. With elevated leverage, routine investments or marketing spends become harder to fund internally, and refinancing or cyclical revenue dips could stress liquidity over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross Margin Strength
Sustained gross margins near 60–64% provide durable unit economics for H&H, enabling the company to absorb channel discounts, promotions and some input-cost pressure while still funding marketing and innovation. This margin buffer supports stable gross profit and long-term reinvestment capacity.
Read all positive factors

Health and Happiness (H&H) International Holdings (1112) vs. iShares MSCI Hong Kong ETF (EWH)

Health and Happiness (H&H) International Holdings Business Overview & Revenue Model

Company Description
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under s...
How the Company Makes Money
H&H makes money mainly by selling branded nutrition and wellness products to consumers through multiple go-to-market channels. Revenue is generated from (1) direct sales via e-commerce platforms and the company’s own online storefronts where it ea...

Health and Happiness (H&H) International Holdings Financial Statement Overview

Summary
Strong gross margins and consistently positive free cash flow support the business, but earnings have been volatile (2024 loss followed by only a thin 2025 profit) and leverage remains elevated, resulting in weak recent ROE and higher sensitivity to profitability swings.
Income Statement
58
Neutral
Balance Sheet
46
Neutral
Cash Flow
62
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue14.35B13.05B13.93B12.78B11.55B
Gross Profit8.96B7.92B8.47B7.70B7.25B
EBITDA1.78B1.37B2.04B1.87B1.42B
Net Income196.14M-53.72M581.85M611.78M508.48M
Balance Sheet
Total Assets19.41B18.84B20.04B20.96B20.28B
Cash, Cash Equivalents and Short-Term Investments1.73B1.60B1.45B2.30B2.40B
Total Debt9.06B9.36B9.22B9.67B9.48B
Total Liabilities13.42B13.03B13.75B14.82B14.40B
Stockholders Equity5.99B5.81B6.30B6.14B5.89B
Cash Flow
Free Cash Flow947.13M1.25B1.01B1.37B1.78B
Operating Cash Flow994.38M1.35B1.10B1.47B1.89B
Investing Cash Flow-134.75M895.00K-52.07M-104.88M-4.01B
Financing Cash Flow-794.56M-1.07B-1.99B-1.49B2.77B

Health and Happiness (H&H) International Holdings Technical Analysis

Technical Analysis Sentiment
Negative
Last Price14.19
Price Trends
50DMA
13.11
Negative
100DMA
13.69
Negative
200DMA
13.36
Negative
Market Momentum
MACD
-0.03
Positive
RSI
37.95
Neutral
STOCH
-0.79
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1112, the sentiment is Negative. The current price of 14.19 is above the 20-day moving average (MA) of 13.78, above the 50-day MA of 13.11, and above the 200-day MA of 13.36, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 37.95 is Neutral, neither overbought nor oversold. The STOCH value of -0.79 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1112.

Health and Happiness (H&H) International Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
HK$49.09B8.3723.50%3.26%2.03%1.43%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
62
Neutral
HK$29.25B8.887.69%6.70%-12.70%-45.69%
59
Neutral
HK$67.12B-26.783.79%3.62%-7.24%1390.75%
58
Neutral
HK$6.54B13.007.63%2.21%-3.39%91.63%
49
Neutral
HK$8.23B15.373.23%1.77%10.02%
48
Neutral
HK$2.51B9.612.84%2.90%1.14%-25.47%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1112
Health and Happiness (H&H) International Holdings
12.64
-0.73
-5.47%
HK:0151
Want Want China Holdings
4.08
-0.93
-18.61%
HK:2319
China Mengniu Dairy Co
17.40
-0.42
-2.33%
HK:0345
Vitasoy International Holdings
6.30
-2.73
-30.24%
HK:1717
Ausnutria Dairy Corp. Ltd.
1.38
-0.51
-26.95%
HK:6186
China Feihe Limited
3.28
-2.40
-42.25%

Health and Happiness (H&H) International Holdings Corporate Events

H&H Shareholders Approve 2025 Results, Dividend and Capital Mandates at AGM
May 15, 2026
Health and Happiness (HH) International Holdings reported that all resolutions at its 15 May 2026 annual general meeting were approved by poll, including adoption of the 2025 audited financial statements and a final dividend of HK$0.16 per share f...
H&H Delivers Strong Q1 Revenue Growth on China-Driven Nutrition Demand and Deleveraging
Apr 22, 2026
Health and Happiness (HH) International Holdings reported a 34.4% year-on-year rise in first-quarter 2026 revenue to RMB4.26 billion, with high-margin nutritional supplements contributing nearly 60% of sales. Growth was broad-based across adult, b...
H&H Sets 2026 AGM to Approve 2025 Results, Dividend and Share Issue Mandate
Apr 10, 2026
Health and Happiness (HH) International Holdings has called its annual general meeting for 15 May 2026 in Hong Kong, where shareholders will review and adopt the audited consolidated financial statements and directors’ and auditors’ re...
H&H International Returns to Profit on Higher Revenue and Stronger Margins in 2025
Mar 24, 2026
Health and Happiness (HH) International Holdings reported a solid improvement in its 2025 financial performance, with revenue rising 10.0% year-on-year to RMB14.35 billion and gross profit increasing 13.2% to RMB8.96 billion. The group swung from ...
H&H International Declares Final Dividend of HKD 0.16 Per Share for 2025
Mar 24, 2026
Health and Happiness (HH) International Holdings Limited has declared a final ordinary cash dividend of HKD 0.16 per share for the financial year ended 31 December 2025. The payout, subject to shareholder approval on 15 May 2026, underscores the c...
H&H flags double-digit 2025 revenue growth and higher earnings on broad-based demand
Mar 3, 2026
Health and Happiness (HH) International Holdings reported low double-digit revenue growth for 2025 on both reported and like-for-like bases, driven by gains across its adult, baby and pet nutrition segments. The company said Chinese mainland and o...
H&H Schedules March Board Meeting to Approve 2025 Annual Results and Consider Dividend
Mar 2, 2026
Health and Happiness (HH) International Holdings has scheduled a board meeting in Hong Kong on 24 March 2026 to review and approve the group’s annual results for the financial year ended 31 December 2025. The board will also consider recomme...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 26, 2026